These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12654419)

  • 41. [Pulsed-dose rate brachytherapy in cervical cancers: why, how?].
    Mazeron R; Dumas I; Martin V; Martinetti F; Benhabib-Boukhelif W; Gensse MC; Chargari C; Guemnie-Tafo A; Haie-Méder C
    Cancer Radiother; 2014 Oct; 18(5-6):447-51. PubMed ID: 25155782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer.
    Terahara A; Nakano T; Ishikawa A; Morita S; Tsuji H
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):549-54. PubMed ID: 8655379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating contemporary radiotherapy approaches in the primary treatment of cervical cancer.
    Samant R; Kobeleva S; E C; Balaraj K; Le T; Fung-Kee-Fung M
    Int J Gynecol Cancer; 2010 Aug; 20(6):1087-91. PubMed ID: 20683423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One year experience of high dose-rate afterloading brachytherapy in the treatment of cervical cancer.
    Liu MT; Chung CH
    Sonderb Strahlenther Onkol; 1988; 82():205-10. PubMed ID: 3134718
    [No Abstract]   [Full Text] [Related]  

  • 49. [Analysis of intracavitary radiation therapy of uterine cervix cancer--comparison between low dose rate and high dose rate intracavitary radiation therapy using multivariable analysis].
    Kikuchi Y; Nishino S; Takahashi K; Asano A; Yoshikawa H; Amoh K; Fujita M; Uekita Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1185-94. PubMed ID: 3430012
    [No Abstract]   [Full Text] [Related]  

  • 50. High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis.
    Lee KK; Lee JY; Nam JM; Kim CB; Park KR
    Brachytherapy; 2015; 14(4):449-57. PubMed ID: 25906951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix.
    Forrest JL; Ackerman I; Barbera L; Barnes EA; Davidson M; Kiss A; Thomas G
    Int J Gynecol Cancer; 2010 Aug; 20(6):1074-8. PubMed ID: 20683420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix.
    Patel FD; Kumar P; Karunanidhi G; Sharma SC; Kapoor R
    Brachytherapy; 2011; 10(2):147-53. PubMed ID: 20685179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates.
    Demanes DJ; Rodriguez RR; Bendre DD; Ewing TL
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):105-12. PubMed ID: 10477013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fractionation is important for HDR cervix cancer brachytherapy.
    Orton CG
    Int J Radiat Oncol Biol Phys; 1992; 22(1):222-3. PubMed ID: 1727122
    [No Abstract]   [Full Text] [Related]  

  • 56. Cervical cancer brachytherapy in Canada: A focus on interstitial brachytherapy utilization.
    Taggar AS; Phan T; Traptow L; Banerjee R; Doll CM
    Brachytherapy; 2017; 16(1):161-166. PubMed ID: 27914911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
    Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
    Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Isolated pelvic recurrences of cervical carcinoma treated with salvage chemoradiotherapy].
    Besson N; Touboul E; Daraï É; Lefranc JP; Monnier L; Schlienger M; Huguet F
    Cancer Radiother; 2014 Mar; 18(2):83-8. PubMed ID: 24462252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
    Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
    Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
    Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.